drugset / Trial / NCT06033222

A Study of Perturbation of Human Small Intestinal Colonic Permeability

NCT06033222 ↗

Phase 0 Completed 24 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to evaluate the effect of castor oil versus placebo on intestinal permeability in healthy individuals.

Timeline

Start
2024-01-08
Primary completion
2024-05-23
Completion
2024-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ricinoleic Acid Small molecule 750 mg Oral
Subject Ricinoleic Acid Small molecule 1500 mg Oral
Subject Ricinoleic Acid Small molecule 3000 mg Oral

Indications

No indication recorded.